Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States

被引：0
|
作者：
Pierce, J. B. [1 ]
Vaduganathan, M. [2 ]
Fonarow, G. C. [3 ]
Ikeaba, U. [4 ]
Chiswell, K. [4 ]
Huang, J. [5 ]
Linganathan, K. [5 ]
Mcdermott, J. [5 ]
Greene, S. J. Stephen [4 ]
机构：
[1] Duke Univ, Sch Med, Durham, NC 27706 USA
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Duke Clin Res Inst, Durham, NC USA
[5] AstraZeneca, Wilmington, DE USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 67
页数：2
相关论文
共 50 条
  • [41] Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
    Carnicelli, Anthony P.
    Li, Zhen
    Greiner, Melissa A.
    Lippmann, Steven J.
    Greene, Stephen J.
    Mentz, Robert J.
    Hardy, N. Chantelle
    Blumer, Vanessa
    Shen, Xian
    Yancy, Clyde W.
    Peterson, Pamela N.
    Allen, Larry A.
    Fonarow, Gregg C.
    O'Brien, Emily C.
    JACC-HEART FAILURE, 2021, 9 (12) : 876 - 886
  • [42] Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction
    Starr, Jessica A.
    Pinner, Nathan A.
    Lisenby, Katelin M.
    Osmonson, Alyssa
    PHARMACOTHERAPY, 2021, 41 (06): : 526 - 536
  • [43] Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States
    Yan, Brandon W. W.
    Spahillari, Aferdita
    Pandya, Ankur
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (06): : 401 - 410
  • [44] APPLICABILITY OF USE OF SODIUM- GLUCOSE CO-TRANSPORTER-2 INHIBITORS (SGLT2I) IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AT LONDON NORTHWEST UNIVERSITY HEATHCARE NHS TRUST
    Lakra, Oltiana
    Sharma, Angelica
    Al-Dulaimi, Zahraa
    Sethi, Jaskaran
    Hui, Elaine
    Shah, Jaymin S.
    HEART, 2021, 107 : A105 - A105
  • [45] SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?
    Raschi, Emanuel
    Fadini, Gian Paolo
    Diemberger, Igor
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (05) : 647 - 650
  • [46] Cardiac remodeling with SGLT2 inhibitors in heart failure with reduced ejection fraction
    Romeo, Francisco J.
    Del Buono, Marco G.
    Aguilar-gallardo, Jose S.
    Lorente-ros, Marta
    Damonte, Juan I.
    Chiabrando, Juan G.
    Dixon, Dave L.
    Biondi-zoccai, Giuseppe
    Abbate, Antonio
    Carbone, Salvatore
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024, 72 (01) : 95 - 97
  • [47] Baroreflex activation therapy in patients with heart failure and reduced ejection fraction
    Clemencia, David Cordero
    Panadero, Clemencia de Rueda
    Baguda, Javier de Juan
    Bueno, Manuel Gomez
    Robles-Mezcua, Ainhoa
    Alvarez-Garcia, Jesu
    REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (04):
  • [48] Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction
    Zile, Michael R.
    Lindenfeld, Joann
    Weaver, Fred A.
    Zannad, Faiez
    Galle, Elizabeth
    Rogers, Tyson
    Abraham, William T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (01) : 1 - 13
  • [49] Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction
    Ruddy, Jean M.
    Kroman, Anne
    Baicu, Catalin F.
    Zile, Michael R.
    HEART FAILURE CLINICS, 2024, 20 (01) : 39 - 50
  • [50] Frailty and use of treatment in patients with heart failure and reduced ejection fraction
    Kondo, T.
    Adachi, T.
    Kobayashi, K.
    Okumura, T.
    Izawa, H.
    Murohara, T.
    McMurray, J. J. V.
    Yamada, S.
    EUROPEAN HEART JOURNAL, 2022, 43 : 965 - 965
12345